ATF3 and HNF4A: an oxidative phosphorylation and cholesterol homeostasis-associated diagnostic and therapeutic repurposing framework target for metabolic dysfunction-associated steatohepatitis patients - Summary - MDSpire
Advertisement
ATF3 and HNF4A: an oxidative phosphorylation and cholesterol homeostasis-associated diagnostic and therapeutic repurposing framework target for metabolic dysfunction-associated steatohepatitis patients
To investigate the role of oxidative phosphorylation and cholesterol homeostasis in metabolic dysfunction-associated steatohepatitis (MASH) and identify potential diagnostic targets.
Approach:
Data Analysis: Utilized GSVA and WGCNA to identify OC-associated gene modules and DEGs from MASH hepatic profiles.
Machine Learning: Integrated machine learning algorithms to identify hub variables and construct a diagnostic model.
Drug Repurposing: Employed molecular docking and deep learning to identify potential therapeutic agents targeting hub variables.
In Vitro Study: Examined expression patterns of hub variables in MASH cell lines compared to normal cell lines.
Key Findings:
ATF3 and HNF4A were identified as hub variables associated with MASH pathogenesis.
Alverine and Mecamylamine were proposed as potential therapeutic approaches for MASH treatment.
The study established an OC-associated diagnostic model with satisfactory performance.
Interpretation:
Limitations:
The study relies on bioinformatic analyses and may require further validation in clinical settings.
Potential variability in gene expression across different populations was not addressed.
Conclusion:
The findings indicate that ATF3 and HNF4A may serve as diagnostic targets for MASH patients.
